JCV is a DNA polyomavirus and the primary aetiological agent of PML. Most adults carry JCV in its latent form, but the virus ...

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Up to 30% of children with juvenile arthritis develop uveitis, an eye inflammation that can damage vision. New research ...

The funding will scale Antiverse’s AI-driven antibody discovery platform for partners while advancing its proprietary ...

Researchers identified a blood immune signature linked to amyloid-related imaging abnormalities in patients receiving ...

Dung beetles are paralysed by excessive wormer use, and overscrupulous poo-picking is bad for their habitats ...

Funding to accelerate internal pipeline and advance lead antibody programs toward in vivo efficacy studiesAI-driven, ...

Antibody therapies work in part by binding to Fcγ receptors, proteins found on immune cells that control key immune functions such as antibody-mediated cell killing and inflammation. Since these ...

Antiverse funding, AI antibody discovery, biotech Series A Europe, computational drug discovery, therapeutic antibody design.

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source ...

With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...